Fair Value Measurements (Tables)

12 Months Ended

Jan. 31, 2023

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

The Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows:


	Fair Value Measured as of January 31, 2023
	Level 1		Level 2		Level 3		Total
	( in thousands)
Assets
Money market funds	$	133,979	$	—	$	—	$	133,979
U.S. Treasury securities	—		104,966		—		104,966
Total financial assets	$	133,979	$	104,966	$	—	$	238,945


	Fair Value Measured as of January 31, 2022
	Level 1		Level 2		Level 3		Total
	( in thousands)
Assets
Money market funds	$	254,716	$	—	$	—	$	254,716
Total financial assets	$	254,716	$	—	$	—	$	254,716
Liabilities
Common stock warrant liabilities (Private Placement)	$	—	$	—	$	25	$	25
Contingent earnout liability recognized upon acquisition of ViriCiti (ViriCiti Earnout)	—		—		5,993		5,993
Total financial liabilities	$	—	$	—	$	6,018	$	6,018

Summary of Changes in the Fair Value of the Company's Level 3 Financial Instruments

The following table presents a summary of the changes in the fair value of the Company’s Level 3 financial instruments:


	Redeemable convertible preferred stock warrant liability		Private placement warrant liability		Earnout liability		ViriCiti Earnout liability
	(in thousands)
Fair value as of January 31, 2020	$	(2,718)	$	—	$	—	$	—
Change in fair value included in other income (expense), net	(73,125)		—		—		—
Fair value as of January 31, 2021	$	(75,843)	$	—	$	—	$	—
Private placement warrant liability acquired as part of the Merger	—		(127,888)		—		—
Contingent earnout liability recognized upon the closing of the reverse recapitalization	—		—		(828,180)		—
Contingent earnout liability recognized upon the acquisition of ViriCiti (“ViriCiti Earnout”)	—		—		—		(3,856)
Change in fair value	9,237		63,746		84,420		(2,137)
Reclassification of warrants to stockholders’ equity (deficit) due to exercise	—		64,117		—		—
Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reverse capitalization	66,606		—		—		—
Issuance of earnout shares upon triggering events	—		—		501,120		—
Reclassification of remaining contingent earnout liability upon triggering event	—		—		242,640		—
Fair value as of January 31, 2022	$	—	$	(25)	$	—	$	(5,993)
Change in fair value included in other income (expense), net	—		(23)		—		—
Effect of foreign currency translation	—		—		—		191
Reclassification of warrants to stockholder’s equity (deficit) due to exercise	—		48		—		—
Contingent earnout liability increase upon satisfaction of earnings goal of ViriCiti (ViriCiti Earnout)	—		—		—		(1,283)
Transfer out of Level 3 upon achievement of earnings target for the earnout period	—		—		—		7,085
Fair Value as of January 31, 2023	$	—	$	—	$	—	$	—